[11C]BMT-136088

N/A

Report date: 2026/03/13 20:02:36

Base Information

Drug Name[11C]BMT-136088
Drug Alias Name[11C]BMT-136088
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5
Mechanisms of ActionPositron-emission tomography enhancers
TargetsLysophosphatidic acid receptor Edg-2
Therapy Area/IndicationsDiagnostic agentsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiagnostic agentsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A